Catalent
CTLT
#1586
Rank
โ‚ฌ10.29 B
Marketcap
56,74ย โ‚ฌ
Share price
1.35%
Change (1 day)
55.54%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ5.85 Billion

According to Catalent's latest financial reports the company's total liabilities are โ‚ฌ5.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚ฌ5.67 B3.38%
2022-06-30โ‚ฌ5.48 B35.01%
2021-06-30โ‚ฌ4.06 B7.04%
2020-06-30โ‚ฌ3.79 B11.02%
2019-06-30โ‚ฌ3.42 B16.22%
2018-06-30โ‚ฌ2.94 B23.31%
2017-06-30โ‚ฌ2.38 B8.18%
2016-06-30โ‚ฌ2.20 B-1.12%
2015-06-30โ‚ฌ2.23 B-12.06%
2014-06-30โ‚ฌ2.53 B-1.75%
2013-06-30โ‚ฌ2.58 B-6.33%
2012-06-30โ‚ฌ2.75 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.31 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.51 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.67 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ0.30 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA